icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria april 22-26
Back grey_arrow_rt.gif
 
 
 
Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in HBeAg-negative, genotype D chronic hepatitis B patients fully suppressed on nucleot(s)ide analogue treatment The HERMES Study
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Pietro Lampertico1, Maurizia R. Brunetto2, Antonio Crax3, Giovanni B. Gaeta4, Mario Rizzetto5, Giulio Palmieri6, Massimo Colombo1 on behalf of the HERMES Study Team
1Division of Gastroenterology and Hepatology, Ospedale Maggiore Policlinico, University of Milan, Italy
2Liver Unit, Reference Centre for Chronic Liver Disease and HCC of the Tuscany Region, University Hospital of Pisa, Italy;
3Gastroenterology and Hepatology, Di.Bi.M.I.S., University of Palermo, Italy; 4Department of Internal Medicine, Section of Infectious Disease, Second University of Naples, Italy;
5Department of Gastroenterology, University of Turin, Italy; 6Roche S.p.A., Monza, Italy

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif